Home › Aortic Valve Stenosis › Illinois › Chicago
Aortic Valve Stenosis clinical trials in Chicago, IL
6 studies for Aortic Valve Stenosis are looking for participants at sites in and around Chicago (within about 30 miles). Open a study to see who can join and how to contact the study team.
Study of the Progression of Chronic Cardiovascular Conditions
RecruitingObservational study
- Prolaio, Chicago
Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study
RecruitingPhase 2/3
- Northwestern University The Feinberg School of Medicine, Chicago
Correlation Between an Impedance Cardiography Test for Decompensation and the Development of Left Ventricular Replacement Fibrosis
Recruiting
- Northwestern University, Chicago
PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR
Recruiting
- Rush University Medical Center, Chicago
Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement
Recruiting
- Ascension Alexian Brothers, Chicago
PARTNER 3 Trial - Aortic Valve-in-Valve
Recruiting
- Northwestern University Hospital, Chicago
- Rush University Medical Center, Chicago
Aortic Valve Stenosis trials in other cities
- Boston, MA10 studies
- San Francisco, CA9 studies
- New York City, NY9 studies
- Cleveland, OH8 studies
- Cincinnati, OH7 studies
- Mountain View, CA7 studies
- Houston, TX7 studies
- Rochester, MN6 studies
- Los Angeles, CA6 studies
- Plano, TX6 studies
- Nashville, TN6 studies
- Pittsburgh, PA6 studies
Other studies in Chicago
- Non-Small Cell Lung Cancer62 studies
- Breast Cancer58 studies
- Cancer (all types)52 studies
- Prostate Cancer45 studies
- Metastatic Cancer45 studies
- Lung Cancer41 studies
- Obesity41 studies
- Ovarian Cancer37 studies
- Stroke35 studies
- Heart Failure32 studies
- Colorectal Cancer32 studies
- Overweight27 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.